| 1 |
35466109 | Effects of Subdiaphragmatic Vagotomy in the MPTP-induced Neurotoxicity in the Striatum and Colon of Mice. | 2022 May 31 |
1 |
| 2 |
35625810 | Toxic Exposure to Endocrine Disruptors Worsens Parkinson's Disease Progression through NRF2/HO-1 Alteration. | 2022 May 5 |
1 |
| 3 |
34560239 | Regulation of neurotoxicity in the striatum and colon of MPTP-induced Parkinson's disease mice by gut microbiome. | 2021 Dec |
2 |
| 4 |
31418048 | MPTP-induced dopaminergic neurotoxicity in mouse brain is attenuated after subsequent intranasal administration of (R)-ketamine: a role of TrkB signaling. | 2020 Jan |
8 |
| 5 |
32387710 | Glyphosate exposure exacerbates the dopaminergic neurotoxicity in the mouse brain after repeated administration of MPTP. | 2020 Jun 21 |
1 |
| 6 |
32848705 | Lactulose and Melibiose Attenuate MPTP-Induced Parkinson's Disease in Mice by Inhibition of Oxidative Stress, Reduction of Neuroinflammation and Up-Regulation of Autophagy. | 2020 |
2 |
| 7 |
30590105 | c-Jun/Bim Upregulation in Dopaminergic Neurons Promotes Neurodegeneration in the MPTP Mouse Model of Parkinson's Disease. | 2019 Feb 10 |
1 |
| 8 |
31105522 | Lipostatic Mechanisms Preserving Cerebellar Lipids in MPTP-Treated Mice: Focus on Membrane Microdomains and Lipid-Related Gene Expression. | 2019 |
3 |
| 9 |
31132231 | Dietary intake of glucoraphanin prevents the reduction of dopamine transporter in the mouse striatum after repeated administration of MPTP. | 2019 Sep |
6 |
| 10 |
31445131 | Total glucosides of paeony (TGP) extracted from Radix Paeoniae Alba exerts neuroprotective effects in MPTP-induced experimental parkinsonism by regulating the cAMP/PKA/CREB signaling pathway. | 2019 Dec 5 |
2 |
| 11 |
31479418 | Antibiotic-induced microbiome depletion protects against MPTP-induced dopaminergic neurotoxicity in the brain. | 2019 Sep 3 |
2 |
| 12 |
31583052 | Salidroside Protects Dopaminergic Neurons by Enhancing PINK1/Parkin-Mediated Mitophagy. | 2019 |
1 |
| 13 |
29332269 | Behavioral, Biochemical and Molecular Characterization of a Parkinson's Disease Mouse Model Using the Neurotoxin 2'-CH3-MPTP: A Novel Approach. | 2018 Mar |
1 |
| 14 |
28377118 | Single low doses of MPTP decrease tyrosine hydroxylase expression in the absence of overt neuron loss. | 2017 May |
2 |
| 15 |
28734031 | Downregulation of DEC1 contributes to the neurotoxicity induced by MPP+ by suppressing PI3K/Akt/GSK3β pathway. | 2017 Sep |
2 |
| 16 |
28830769 | Plasmalogen precursor mitigates striatal dopamine loss in MPTP mice. | 2017 Nov 1 |
2 |
| 17 |
26827716 | Neuroprotective effects of stemazole in the MPTP-induced acute model of Parkinson's disease: Involvement of the dopamine system. | 2016 Mar 11 |
1 |
| 18 |
26828289 | Neuroprotective effect of fucoidan from Turbinaria decurrens in MPTP intoxicated Parkinsonic mice. | 2016 May |
1 |
| 19 |
26959819 | Plasmalogen Augmentation Reverses Striatal Dopamine Loss in MPTP Mice. | 2016 |
2 |
| 20 |
25447236 | Increased expression of the dopamine transporter leads to loss of dopamine neurons, oxidative stress and l-DOPA reversible motor deficits. | 2015 Feb |
1 |
| 21 |
25943481 | Intervention with exercise restores motor deficits but not nigrostriatal loss in a progressive MPTP mouse model of Parkinson's disease. | 2015 Jul 23 |
1 |
| 22 |
26006269 | The 5α-reductase inhibitor Dutasteride but not Finasteride protects dopamine neurons in the MPTP mouse model of Parkinson's disease. | 2015 Oct |
2 |
| 23 |
26203861 | Sigma-1 receptor deficiency reduces MPTP-induced parkinsonism and death of dopaminergic neurons. | 2015 Jul 23 |
1 |
| 24 |
24648001 | Wnt/β-catenin signaling is required to rescue midbrain dopaminergic progenitors and promote neurorepair in ageing mouse model of Parkinson's disease. | 2014 Aug |
1 |
| 25 |
24657313 | Escin attenuates behavioral impairments, oxidative stress and inflammation in a chronic MPTP/probenecid mouse model of Parkinson's disease. | 2014 Oct 17 |
2 |
| 26 |
24799940 | Neuroprotective Effects of Jitai Tablet, a Traditional Chinese Medicine, on the MPTP-Induced Acute Model of Parkinson's Disease: Involvement of the Dopamine System. | 2014 |
1 |
| 27 |
25064079 | Neuroprotective effect of the chemical chaperone, trehalose in a chronic MPTP-induced Parkinson's disease mouse model. | 2014 Sep |
1 |
| 28 |
21788124 | Neuronal or inducible nitric oxide synthase (NOS) expression level is not involved in the different susceptibility to nigro-striatal dopaminergic neurotoxicity induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) between C57BL/6 and BALB/c mice. | 2013 Jan |
5 |
| 29 |
22281418 | Involvement of monoamine oxidase-B in the acute neurotoxicity of MPTP in embryonic and newborn mice. | 2013 May |
4 |
| 30 |
23911879 | Neuroprotection by tetrahydroxystilbene glucoside in the MPTP mouse model of Parkinson's disease. | 2013 Oct 24 |
1 |
| 31 |
22634505 | Theaflavin ameliorates behavioral deficits, biochemical indices and monoamine transporters expression against subacute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mouse model of Parkinson's disease. | 2012 Aug 30 |
2 |
| 32 |
22885234 | Ginkgo biloba extract (EGb 761) modulates the expression of dopamine-related genes in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice. | 2012 Oct 25 |
1 |
| 33 |
21185886 | Loss of striatal dopaminergic terminals during the early stage in response to MPTP injection in C57BL/6 mice. | 2011 Apr |
2 |
| 34 |
21476268 | [A comparative study of hemantane and amantadine effects on dopamine transporter expression in brain of normal and MPTP-treated C57BL/6 mice]. | 2011 |
1 |
| 35 |
21092260 | Combining nitric oxide release with anti-inflammatory activity preserves nigrostriatal dopaminergic innervation and prevents motor impairment in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. | 2010 Nov 23 |
1 |
| 36 |
19027004 | Role of nuclear transcription factor kappa B (NF-kappaB) for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine)-induced apoptosis in nigral neurons of mice. | 2009 Feb |
2 |
| 37 |
19319673 | MPTP intoxication in mice: a useful model of Leigh syndrome to study mitochondrial diseases in childhood. | 2009 Jun |
1 |
| 38 |
19520064 | Effect of caffeine on the expression of cytochrome P450 1A2, adenosine A2A receptor and dopamine transporter in control and 1-methyl 4-phenyl 1, 2, 3, 6-tetrahydropyridine treated mouse striatum. | 2009 Aug 4 |
2 |
| 39 |
19616025 | MPTP-induced neuroblast apoptosis in the subventricular zone is not regulated by dopamine or other monoamine transporters. | 2009 Nov |
5 |
| 40 |
19631714 | Gender differences on MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in C57BL/6 mice. | 2009 Nov 13 |
2 |
| 41 |
19686731 | Effects of a novel dopamine uptake inhibitor upon extracellular dopamine from superfused murine striatal tissue. | 2009 Oct 1 |
4 |
| 42 |
17920944 | Bak Foong protects dopaminergic neurons against MPTP-induced neurotoxicity by its anti-apoptotic activity. | 2008 Jan |
1 |
| 43 |
18054104 | Neuroprotective effects of genistein on dopaminergic neurons in the mice model of Parkinson's disease. | 2008 Feb |
2 |
| 44 |
18235988 | Role of reactive nitrogen and reactive oxygen species against MPTP neurotoxicity in mice. | 2008 Jun |
2 |
| 45 |
18420351 | Alteration of dopaminergic markers in gastrointestinal tract of different rodent models of Parkinson's disease. | 2008 May 15 |
1 |
| 46 |
17486689 | Toki-to protects dopaminergic neurons in the substantia nigra from neurotoxicity of MPTP in mice. | 2007 Sep |
3 |
| 47 |
17515828 | Lamotrigine is neuroprotective in the energy deficiency model of MPTP intoxicated mice. | 2007 Jul |
1 |
| 48 |
17597311 | Neurotoxicity in murine striatal dopaminergic pathways following long-term application of low doses of permethrin and MPTP. | 2007 Jul 10 |
2 |
| 49 |
16959318 | In vivo modulation of the Parkinsonian phenotype by Nrf2. | 2006 Dec |
2 |
| 50 |
15499605 | Selective alterations of gene expression in mice induced by MPTP. | 2005 Jan |
2 |